PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-58.68%
Negative 5Y CAGR while YAL.AX stands at 70.47%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-69.03%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
91.08%
10Y OCF/share CAGR at 75-90% of YAL.AX's 117.97%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
-120.06%
Negative 5Y OCF/share CAGR while YAL.AX is at 67.53%. Joel Greenblatt would question the firm’s operational model or cost structure.
-128.37%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
98.98%
Net income/share CAGR at 75-90% of YAL.AX's 110.16%. Bill Ackman would press for strategic moves to boost long-term earnings.
76.84%
Below 50% of YAL.AX's 413.54%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
77.05%
Positive short-term CAGR while YAL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
-68.22%
Both are negative. Martin Whitman suspects the segment is in decline or saddled with persistent unprofitability or write-downs.
48.56%
5Y equity/share CAGR is in line with YAL.AX's 51.19%. Walter Schloss would see parallel mid-term profitability and retention policies.
297.14%
3Y equity/share CAGR above 1.5x YAL.AX's 51.61%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.